These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 7733838)

  • 41. Single-blind, placebo-controlled pilot study of pregabalin for ataxia in cortical cerebellar atrophy.
    Gazulla J; Benavente I
    Acta Neurol Scand; 2007 Oct; 116(4):235-8. PubMed ID: 17824901
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Computerized tomography in the study of degenerative ataxia].
    De Michele G; Filla A; Mansi E; Delehaye L; Cirillo S; Di Geronimo G; Geri G; Campanella G
    Riv Neurol; 1987; 57(6):323-7. PubMed ID: 3330622
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Double-blind study of 5-hydroxytryptophan versus placebo in the treatment of primary fibromyalgia syndrome.
    Caruso I; Sarzi Puttini P; Cazzola M; Azzolini V
    J Int Med Res; 1990; 18(3):201-9. PubMed ID: 2193835
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Steroid treatment in four cases of anti-GAD cerebellar ataxia].
    Bonnan M; Cabre P; Olindo S; Signate A; Saint-Vil M; Smadja D
    Rev Neurol (Paris); 2008 May; 164(5):427-33. PubMed ID: 18555874
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects of a levo-5-hydroxytryptophan-dihydroergocristine combination on depression and neuropsychic performance: a double-blind placebo-controlled clinical trial in elderly patients.
    Rousseau JJ
    Clin Ther; 1987; 9(3):267-72. PubMed ID: 3111702
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The handkerchief guide: a simple and practical method to improve ataxic gait in cerebellar subjects.
    Nagumo K; Kunimi Y; Nomura S; Beppu M; Hirayama K
    Rinsho Shinkeigaku; 2015; 55(5):311-9. PubMed ID: 26028193
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Serotonin precursors in chronic primary headache. A double-blind cross-over study with L-5-hydroxytryptophan vs. placebo.
    De Benedittis G; Massei R
    J Neurosurg Sci; 1985; 29(3):239-48. PubMed ID: 3913752
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Degree of cerebellar ataxia correlates with three-dimensional mri-based cerebellar volume in pure cerebellar degeneration.
    Richter S; Dimitrova A; Maschke M; Gizewski E; Beck A; Aurich V; Timmann D
    Eur Neurol; 2005; 54(1):23-7. PubMed ID: 16088175
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Double-blind clinical trial of 5-hydroxytryptophan in a case of Lesch-Nyhan syndrome.
    Frith CD; Johnston EC; Joseph MH; Powell RJ; Watts RW
    J Neurol Neurosurg Psychiatry; 1976 Jul; 39(7):656-62. PubMed ID: 792398
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Buspirone chlorhydrate in the treatment of cerebellar ataxia].
    Andrade-Filho AS; Passos-Almeida J; Andrade-Souza VM; Sena-Pereira LR
    Rev Neurol; 2002 Aug 16-31; 35(4):301-5. PubMed ID: 12235556
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Treatment of cerebellar ataxia with buspirone: a double-blind study.
    Trouillas P; Xie J; Adeleine P
    Lancet; 1996 Sep; 348(9029):759. PubMed ID: 8806320
    [No Abstract]   [Full Text] [Related]  

  • 52. Cerebrospinal fluid as a reflector of central cholinergic and amino acid neurotransmitter activity in cerebellar ataxia.
    Manyam BV; Giacobini E; Ferraro TN; Hare TA
    Arch Neurol; 1990 Nov; 47(11):1194-9. PubMed ID: 1978660
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Placebo response in degenerative cerebellar ataxias: a descriptive review of randomized, placebo-controlled trials.
    Choi JH; Shin C; Kim HJ; Jeon B
    J Neurol; 2022 Jan; 269(1):62-71. PubMed ID: 33219422
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The effect of piracetam on ataxia: clinical observations in a group of autosomal dominant cerebellar ataxia patients.
    Ince Gunal D; Agan K; Afsar N; Borucu D; Us O
    J Clin Pharm Ther; 2008 Apr; 33(2):175-8. PubMed ID: 18315783
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Peripheral nerve involvement in hereditary cerebellar and multisystem degenerative disorders.
    Berciano J; García A; Infante J
    Handb Clin Neurol; 2013; 115():907-32. PubMed ID: 23931821
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Nerve conduction study, electromyography and somatosensory evoked potentials in non-Friedreich early onset cerebellar ataxia. A comparative study with Friedreich's ataxia and late onset cerebellar ataxia.
    Mondelli M; Decchi B; Parlanti S; Scarpini C; Rossi A
    Electromyogr Clin Neurophysiol; 1992; 32(4-5):207-14. PubMed ID: 1600884
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Local Stability of the Trunk in Patients with Degenerative Cerebellar Ataxia During Walking.
    Chini G; Ranavolo A; Draicchio F; Casali C; Conte C; Martino G; Leonardi L; Padua L; Coppola G; Pierelli F; Serrao M
    Cerebellum; 2017 Feb; 16(1):26-33. PubMed ID: 26811155
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Differences in saccade dynamics between spinocerebellar ataxia 2 and late-onset cerebellar ataxias.
    Federighi P; Cevenini G; Dotti MT; Rosini F; Pretegiani E; Federico A; Rufa A
    Brain; 2011 Mar; 134(Pt 3):879-91. PubMed ID: 21354979
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Treatment of cerebellar ataxia with 5-HT1A agonist.
    Takei A; Hamada T; Yabe I; Sasaki H
    Cerebellum; 2005; 4(3):211-5. PubMed ID: 16147954
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A preliminary study of the efficacy of ondansetron in the treatment of ataxia, poor balance and incoordination from brain injury.
    Mandelcorn J; Cullen NK; Bayley MT
    Brain Inj; 2004 Oct; 18(10):1025-39. PubMed ID: 15370901
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.